companies / earlyisgood-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-05 json
| total_raised | 1,700,0001.7M | ○ |
|---|---|---|
| founded | 2022 | |
| hq | indianapolis, in, usa | |
| industry | unknown | |
| stage | null |
Early Is Good runs a multi-omic cancer diagnostic platform that simultaneously profiles DNA, RNA, and proteins from blood or urine samples at attomolar sensitivity. Customers are oncologists and patients making biopsy, treatment, and monitoring calls in bladder and prostate cancer. The company closed seed funding in 2022 around the unified single-sample multi-omic readout.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-01-01 | grant | 1,700,0001.7M | null | ○ |
Cloudflare
| fact | status | src |
|---|---|---|
| Grant, $1.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |